KPV FAQ for Laboratory Researchers
KPV (Lys-Pro-Val) is a C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (alpha-MSH) widely investigated for its anti-inflammatory properties in preclinical research. This technical FAQ addresses key parameters regarding sequence structure, purity verification, laboratory reconstitution, stability protocols, and comparative anti-inflammatory models for qualified research facilities.
Quick answer
KPV (Lys-Pro-Val) is a C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (alpha-MSH) widely investigated for its anti-inflammatory properties in preclinical research. This technical FAQ addresses key parameters regarding sequence structure, purity verification, laboratory reconstitution, stability protocols, and comparative anti-inflammatory models for qualified research facilities.
Key takeaways
- [KPV](/research-peptides/kpv) is a tripeptide defined by the amino acid sequence Lysine-Proline-Valine (Lys-Pro-Val).
- Preclinical investigations demonstrate that [KPV](/research-peptides/kpv) exerts anti-inflammatory effects primarily through the attenuation of nuclear factor kappa B (NF-kB) signaling cascades.
- A primary focus of [KPV](/research-peptides/kpv) research centers on gastrointestinal pathophysiology and mucosal biology.
- Rigorous quality control is paramount when sourcing synthetic peptides for experimental protocols.
Molecular Structure and Biochemical Profile of KPV
KPV is a tripeptide defined by the amino acid sequence Lysine-Proline-Valine (Lys-Pro-Val). Representing the C-terminal residues (amino acids 11–13) of the endogenous pro-opiomelanocortin (POMC) derivative alpha-melanocyte-stimulating hormone, KPV retains the core anti-inflammatory signaling potential of its parent molecule without inducing melanogenesis or activating classical melanocortin-1 receptor (MC1R) pathways in the same manner.
With a low molecular weight of approximately 341.4 g/mol, KPV possesses distinct chemical properties that facilitate cellular uptake and mucosal interaction. In laboratory environments, researchers utilize KPV tripeptide to study peptide-transporter interactions, specifically focusing on its affinity for intestinal oligopeptide transporters such as PepT1 (SLC15A1). Understanding the exact structural parameters and physical characteristics of this sequence is fundamental to designing reproducible in vitro and ex vivo protocols.
Primary Mechanisms of Action in Preclinical Signaling Pathways
Preclinical investigations demonstrate that KPV exerts anti-inflammatory effects primarily through the attenuation of nuclear factor kappa B (NF-kB) signaling cascades. In vitro assays using intestinal epithelial cells and macrophage line cultures indicate that KPV enters cells via PepT1 transporters, where it directly interacts with intracellular targets to inhibit the nuclear translocation of the NF-kB p65 subunit.
By preventing NF-kB activation, KPV downstream reduces the transcription of key pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1beta), and interleukin-6 (IL-6). In vitro data further suggest that KPV alters the expression of inducible nitric oxide synthase (iNOS), diminishing excessive nitric oxide generation during simulated inflammatory stress. Researchers examining systemic and localized inflammatory pathways frequently benchmark KPV against broader alpha-MSH derivatives to isolate sequence-specific signaling mechanisms.
Investigational Applications in Intestinal Barrier and Colitis Models
A primary focus of KPV research centers on gastrointestinal pathophysiology and mucosal biology. In murine models of dextran sulfate sodium (DSS)-induced and trinitrobenzene sulfonic acid (TNBS)-induced colitis, oral or localized administration of KPV demonstrated significant reductions in histological inflammation, mucosal erosion, and neutrophil infiltration.
Mechanistic studies in epithelial cell monolayers indicate that KPV promotes the preservation and restoration of tight junction integrity. Preclinical assays demonstrate up-regulated expression of key barrier proteins, including zonula occludens-1 (ZO-1), occludin, and claudin family members following exposure to inflammatory stimuli. These properties make KPV a standard reference compound for exploring targeted therapeutic delivery systems, such as nanoparticle encapsulation and hydrogel formulations designed for localized gut delivery in gastrointestinal research models.
Synthesis Quality, HPLC Purity, and COA Verification
Rigorous quality control is paramount when sourcing synthetic peptides for experimental protocols. Impurities arising during solid-phase peptide synthesis (SPPS)—such as truncated sequences, deletion peptides, or residual organic solvents—can alter biological assays, cause off-target cellular toxicity, or introduce confounding variables in quantitative assays.
At PX1 Research, every lot of KPV undergoes comprehensive third-party testing within an ISO 17025 accredited laboratory. Analytical testing includes High-Performance Liquid Chromatography (HPLC) to confirm sequence purity exceeds 98% and Mass Spectrometry (MS) to verify precise molecular weight. A lot-specific Certificate of Analysis (COA) detailing raw chromatographic data is provided with every shipment, ensuring investigators receive verified, highly reproducible research reagents.
Endotoxin Limits and Quality Control Standards
Bacterial endotoxins (lipopolysaccharides or LPS) are frequent contaminants in peptide synthesis and processing. In immunological, cell culture, and barrier-function assays, residual endotoxin contamination can artifactually activate Toll-like receptor 4 (TLR4), triggering downstream NF-kB signaling and invalidating experimental measurements of anti-inflammatory efficacy.
To guarantee experimental validity, PX1 Research subjects all research peptides to stringent Limulus Amebocyte Lysate (LAL) testing. KPV batches are certified to contain endotoxin levels well below industry thresholds (<0.01 EU/mg), ensuring suitability for sensitive cell lines, organoid cultures, and delicate tissue explants prepared in sterile laboratory environments.
Laboratory Reconstitution and Handling Protocols
Proper reconstitution procedures are required to maintain structural integrity and prevent enzymatic or chemical degradation. KPV is supplied as a lyophilized (freeze-dried) powder that exhibits high solubility in aqueous buffers due to its hydrophilic lysine and proline residues.
For reconstituting KPV in a laboratory setting, researchers typically use sterile, endotoxin-free water or phosphate-buffered saline (PBS, pH 7.4). If long-term working aliquots are prepared for cell culture applications, sterile bacteriostatic water containing 0.9% benzyl alcohol may be utilized to prevent microbial growth. Reconstitution should be performed under a laminar flow hood using sterile technique. Avoid vigorous vortexing; gentle inversion or swirling is recommended to fully dissolve the lyophilized cake.
Storage Stability and Degradation Mitigation
Lyophilized KPV exhibits excellent thermal stability when stored under proper environmental conditions. Upon receipt, unopened vials should be stored in a freezer at -20°C or -80°C, protected from light and moisture exposure. Under these conditions, the desiccated peptide maintains physical and chemical stability for up to 24 months.
Once reconstituted into solution, KPV aliquots should be used immediately or stored at -20°C or colder to prevent peptide hydrolysis and microbial contamination. Repeated freeze-thaw cycles must be strictly avoided, as thermal fluctuations promote aggregation and peptide bond cleavage. Researchers are advised to prepare single-use working aliquots immediately following initial reconstitution.
Comparative Analysis: KPV vs. Other Anti-Inflammatory Compounds
When designing comparative protocols to assess tissue repair, gut permeability, or broad-spectrum anti-inflammatory activity, researchers often evaluate KPV alongside other established research peptides. While KPV specifically targets intracellular NF-kB pathways and PepT1-mediated epithelial transport, compounds such as BPC-157 operate through distinct angiogenic and growth factor up-regulation mechanisms to promote tissue healing.
Similarly, comparative assays evaluating antimicrobial and immunomodulatory properties frequently contrast KPV with host-defense peptides like LL-37, which exhibits direct bactericidal membrane disruption in addition to immune cell chemotaxis. For targeted intestinal tight-junction modulation, researchers also compare KPV with zonulin antagonists such as Larazotide. Utilizing these distinct peptides in multi-arm in vitro studies allows investigators to delineate non-overlapping cytoprotective pathways.
Sourcing Standards for B2B and Academic Research Facilities
Acquiring high-purity peptides from reliable domestic suppliers is essential for maintaining research continuity and meeting institutional compliance standards. Substandard reagents lead to non-reproducible baseline data, wasted laboratory resources, and corrupted scientific outcomes.
PX1 Research synthesizes all compounds in state-of-the-art, GMP-compliant facilities located within the United States. Operating out of centralized dispatch centers in California and Arizona, PX1 offers same-day shipping (Monday–Friday) for orders placed before standard cutoff times, ensuring rapid turnaround for fast-paced academic, biotech, and pharmaceutical laboratories. Principal investigators and procurement officers seeking scaled reagent quantities can apply for dedicated institutional accounts through our wholesale peptide program.
Frequently Asked Questions
What is the primary biological role of KPV in laboratory research?
KPV is an anti-inflammatory tripeptide derived from alpha-MSH. In preclinical models, it is studied for its ability to inhibit NF-kB nuclear translocation, down-regulate pro-inflammatory cytokines, and preserve tight junction integrity in intestinal epithelial tissues.
What is the molecular weight and sequence of KPV?
KPV consists of the three-amino-acid sequence Lysine-Proline-Valine (Lys-Pro-Val) and has a molecular weight of approximately 341.4 g/mol.
How does KPV gain entry into intestinal epithelial cells during in vitro assays?
In vitro studies indicate that KPV is transported across apical cell membranes via the oligopeptide transporter PepT1 (SLC15A1), allowing it to exert intracellular anti-inflammatory effects.
What purity level is guaranteed for PX1 Research KPV?
Every lot of KPV supplied by PX1 Research is verified via HPLC and Mass Spectrometry to meet or exceed 98% purity. A lot-specific COA is provided with each shipment.
Is PX1 Research KPV tested for bacterial endotoxins?
Yes. All batches undergo formal LAL endotoxin testing to ensure levels remain well below 0.01 EU/mg, preventing endotoxin-induced cell toxicity or baseline inflammatory interference.
How should lyophilized KPV powder be stored upon delivery?
Unopened, lyophilized KPV should be stored at -20°C or -80°C in a dry, dark environment. Under these conditions, the compound remains stable for up to two years.
What is the recommended diluent for reconstituting KPV for cell culture use?
KPV should be reconstituted using sterile, endotoxin-free water or sterile phosphate-buffered saline (PBS, pH 7.4) under a laminar flow hood using sterile technique.
Can reconstituted KPV solutions undergo multiple freeze-thaw cycles?
No. Repeated freeze-thaw cycles can cause peptide degradation and loss of activity. Researchers should dilute the peptide into single-use working aliquots and store them frozen until use.
How does KPV differ functionally from full-length alpha-MSH?
While full-length alpha-MSH activates classical melanocortin receptors (MC1R–MC5R) to induce pigment synthesis and systemic responses, KPV selectively retains anti-inflammatory activity without inducing melanogenesis.
What models are typically used to study KPV's effects on gut health?
KPV is frequently evaluated in DSS-induced and TNBS-induced colitis rodent models, as well as Caco-2 cell monolayer cultures subjected to inflammatory challenge.
Where is PX1 Research KPV synthesized and shipped from?
PX1 Research peptides are USA-synthesized in GMP-compliant facilities and dispatched directly from distribution hubs in California and Arizona with same-day shipping available Monday through Friday.
How can high-volume academic or commercial labs purchase KPV in bulk?
Qualified institutions and commercial research labs can register for bulk pricing and specialized fulfillment options via the PX1 Research wholesale portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.